These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
621 related items for PubMed ID: 25030731
41. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma. Yokoi E, Mabuchi S, Takahashi R, Matsumoto Y, Kuroda H, Kozasa K, Kimura T. J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992 [Abstract] [Full Text] [Related]
43. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma]. Zhou F, Chen F, Pan T, Zhu T, Zhang YL, Zhang P, Tang HR. Zhonghua Fu Chan Ke Za Zhi; 2022 May 25; 57(5):361-369. PubMed ID: 35658327 [Abstract] [Full Text] [Related]
44. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy. Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Yang GF, Li FY. Int J Surg; 2017 Aug 25; 44():1-6. PubMed ID: 28583891 [Abstract] [Full Text] [Related]
45. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy]. Li PP, Li B, Wang YT, Liu SH, Zhang YN, Zhang R, Bai P, Li XG, Wu LY. Zhonghua Fu Chan Ke Za Zhi; 2018 Apr 25; 53(4):248-256. PubMed ID: 29747270 [Abstract] [Full Text] [Related]
46. Daily low-dose Cisplatin-based concurrent chemoradiotherapy for the treatment of cervical cancer in patients 70 years or older. Hanawa S, Mitsuhashi A, Usui H, Yamamoto N, Watanabe-Nemoto M, Nishikimi K, Uehara T, Tate S, Uno T, Shozu M. Int J Gynecol Cancer; 2015 Jun 25; 25(5):891-6. PubMed ID: 25811592 [Abstract] [Full Text] [Related]
47. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study. Qian S, Ye L, Tian YH, Wang LG, Huang ZP, Li F, Hou B, Song N, Chen J, Liu Y, Liu X, Zhou T. Chin J Cancer; 2017 Feb 28; 36(1):24. PubMed ID: 28245859 [Abstract] [Full Text] [Related]
49. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group. Marnitz S, Martus P, Köhler C, Stromberger C, Asse E, Mallmann P, Schmidberger H, Affonso Júnior RJ, Nunes JS, Sehouli J, Budach V. Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):243-53. PubMed ID: 26853333 [Abstract] [Full Text] [Related]
51. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy. Wu N, Su X, Song H, Li Y, Gu F, Sun X, Li X, Cheng G. Cancer Control; 2021 Feb 01; 28():1073274821989307. PubMed ID: 33593091 [Abstract] [Full Text] [Related]
53. Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study. Liu C, Ran X, Wang Z, Zhang K. Chin Clin Oncol; 2023 Aug 01; 12(4):38. PubMed ID: 37699603 [Abstract] [Full Text] [Related]
55. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study. Yin YJ, Li HQ, Sheng XG, Du XL, Wang C, Lu CH, Pan CX. Int J Gynecol Cancer; 2015 Jul 01; 25(6):1058-65. PubMed ID: 25647254 [Abstract] [Full Text] [Related]
59. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J. Int J Gynecol Cancer; 2010 Aug 01; 20(6):1000-5. PubMed ID: 20683408 [Abstract] [Full Text] [Related]